Zobrazeno 1 - 10
of 1 388
pro vyhledávání: '"Frölich JC"'
Publikováno v:
Der Internist. 50:1281-1289
The goal of drug therapy to prolong life or to improve the quality of life can be accomplished by modern drug therapy to a respectable degree. However, the risks of drug therapy have increased through more specific drugs and lead to often surprisingl
Autor:
Hackett, Geoffrey1,2 hackettgeoff@gmail.com, Mann, Amar3, Haider, Ahmad4, Haider, Karim S.4, Desnerck, Pieter5, König, Carola S.6, Strange, Richard C.7, Ramachandran, Sudarshan3,6,7,8
Publikováno v:
World Journal of Men's Health. Oct2024, Vol. 42 Issue 4, p749-761. 13p.
Autor:
Fewkes, Juanita J.1,2 (AUTHOR), Dordevic, Aimee L.1,2 (AUTHOR), Murray, Margaret1,3 (AUTHOR), Williamson, Gary1,2 (AUTHOR), Kellow, Nicole J.1,4 (AUTHOR) nicole.kellow@monash.edu
Publikováno v:
Cardiovascular Diabetology. 9/9/2024, Vol. 23 Issue 1, p1-11. 11p.
Autor:
ÖZEN, Gürkan1 gurkanozen@baskent.edu.tr, NEMUTLU, Emirhan2
Publikováno v:
Journal of Research in Pharmacy. 2024, Vol. 28 Issue 5, p1777-1790. 14p.
Autor:
Pedrazini, Maria Cristina1 (AUTHOR) m860702@dac.unicamp.br, Martinez, Elizabeth Ferreira2 (AUTHOR), dos Santos, Victor Augusto Benedicto1 (AUTHOR), Groppo, Francisco Carlos1 (AUTHOR)
Publikováno v:
Future Journal of Pharmaceutical Sciences. 8/8/2024, Vol. 10 Issue 1, p1-18. 18p.
Autor:
Frölich Jc, D.O. Stichtenoth
Publikováno v:
Der Internist. 42:421-426
Nicht-steroidale Antirheumatika (NSAR) entfalten ihre therapeutischen und unerwunschten Effekte durch Hemmung der Zyklooxygenase (COX), einem Schlusselenzym der Prostanoidsynthese. Seit 1990 ist bekannt, dass die physiologische Prostanoidsynthese dur
Autor:
M. Galanski, Frölich Jc, Hartmut Hecker, Klaus Alexander, Ranke C, Luska G, H. J. Avenarius, Wagner Hh, Andreas Creutzig, Stefanie M. Bode-Böger
Publikováno v:
The Clinical Investigator. 72:673-680
Percutaneous transluminal angioplasty of aortoiliac and femoropopliteal atherosclerotic lesions can provide long-lasting hemodynamic improvement. High-dose aspirin is commonly prescribed as reocclusion prophylaxis, but low doses would be preferable b
Autor:
Richters, Constanze1,2 (AUTHOR), Schmidmaier, Ralf3,4 (AUTHOR), Popov, Vitaliy5,6 (AUTHOR), Schredelseker, Johann1,2,7,8 (AUTHOR), Fischer, Frank9,10 (AUTHOR) martin.fischer@med.uni-muenchen.de, Fischer, Martin R.1,2 (AUTHOR) martin.fischer@med.uni-muenchen.de
Publikováno v:
GMS Journal for Medical Education. 2024, Vol. 41 Issue 4, p1-15. 15p.
Publikováno v:
7. Deutscher Kongress für Versorgungsforschung des Deutschen Netzwerks für Versorgungsforschung; 20081016-20081018; Köln; DOCP6.4 /20081006/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1175::d86eb108e517f1fc6cc44f9fbd214903
http://www.egms.de/en/meetings/dkvf2008/08dkvf177.shtml
http://www.egms.de/en/meetings/dkvf2008/08dkvf177.shtml
Autor:
Morito K; Laboratory of Environmental Biochemistry, Division of Biological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan., Ali H; Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan., Kishino S; Graduate School of Agriculture, Kyoto University, Kyoto, Japan., Tanaka T; Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima, Japan. tanaka.tamotsu@tokushima-u.ac.jp.
Publikováno v:
Advances in experimental medicine and biology [Adv Exp Med Biol] 2024 May 30. Date of Electronic Publication: 2024 May 30.